Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
- PMID: 40655825
- PMCID: PMC12244763
- DOI: 10.4103/jpbs.jpbs_581_25
Clinical, Epidemiological, and Immunohematological Profile of Hemolytic Uremic Syndrome in Children Between 6 Months and 12 Years at a Tertiary Care Center in South India
Abstract
Background: Hemolytic uremic syndrome (HUS) is a common cause of community acquired acute kidney injury (AKI) in childhood.
Methodology: This descriptive study was conducted on 24 children from May 2019 to September 2020 at the Institute of Child Health and Hospital for Children, Chennai.
Results: Among the study population, 62.5% of children had atypical hemolytic uremic syndrome (HUS) and 37.5% had typical HUS. The prevalence of HUS was equal between girls and boys in the study population. The mortality rate was higher in girls compared to boys. The progression to chronic kidney disease (CKD) was also more in girls. Clinical findings that were statistically significant concerning the overall outcome of this study were hypertension, acidotic breathing, and encephalopathy. The mean hemoglobin level is 5.8 g/dL and the association of hemoglobin with outcome was not statistically significant. Mortality was high in extremes of ages.
Conclusion: High lactate dehydrogenase (LDH) was associated with poor outcomes whereas normal C3 and early hematology resolution were associated with better outcomes.
Keywords: Children; hemolytic uremic syndrome; immunohematological.
Copyright: © 2025 Journal of Pharmacy and Bioallied Sciences.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Anti- Compliment Factor H Antibody Associated Hemolytic Uremic Syndrome in Children with Abbreviated Plasma Exchanges: A 12-Month Follow-up Study.Iran J Kidney Dis. 2021 Dec;15(6):419-425. doi: 10.52547/ijkd.6507. Iran J Kidney Dis. 2021. PMID: 34930853
-
Adult Hemolytic Uremic Syndrome as a Diagnostic Challenge.Cureus. 2025 Jul 7;17(7):e87406. doi: 10.7759/cureus.87406. eCollection 2025 Jul. Cureus. 2025. PMID: 40772201 Free PMC article.
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome - a case-series report.BMC Pediatr. 2025 Mar 11;25(1):181. doi: 10.1186/s12887-025-05546-3. BMC Pediatr. 2025. PMID: 40065282 Free PMC article.
References
-
- Behrman RE, Kliegman RM, Jenson HB. Philadelphia: W. B. Saunders Co; 2000. Nelson Textbook of Pediatrics; p. 2507.
-
- Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. Hemolytic-uremic syndrome: Bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955;85:905–9. - PubMed
-
- Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J. Treatment of the childhood hemolytic-uremic syndrome with plasma. A multi-center randomized controlled trial. The French society of paediatric nephrology. Pediatr Nephrol. 1988;2:279–85. - PubMed
-
- Jha DK, Singh R, Raja S, Kumari N, Das BK. Clinico-laboratory profile of haemolytic uremic syndrome. Kathmandu Univ Med J (KUMJ) 2007;5:468–74. - PubMed
-
- Malla K, Malla T, Hanif M. Prognostic indicators in haemolytic uraemic syndrome. Kathmandu Univ Med J (KUMJ) 2004;2:291–6. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous